Laparoscopic splenectomy for hematologic diseases

Kazuo Tanoue, Keishi Okita, Tomohiko Akahoshi, Kouzou Konishi, Norikazu Gotoh, Norifumi Tsutsumi, Morimasa Tomikawa, Makoto Hashizume

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background. Laparoscopic splenectomy has been demonstrated to be technically feasible and safe for the treatment of hematologic diseases. Methods. The study comprised 64 consecutive patients with chronic immune thrombocytopenia purpura (ITP) who were admitted to our hospital from 1992 to 2000 and underwent laparoscopic splenectomy. Forty-one consecutive patients with ITP who underwent open splenectomy performed at the same hospital by the same surgical team between 1986 and 2000 were selected as the control group. Results. We performed laparoscopic splenectomies for ITP, hereditary spherocytosis (HS), malignant lymphoma, autoimmune hemolytic anemia, and cryoglobulinemia. Laparoscopic surgery as compared with open surgery in ITP revealed a significantly lower pain medication requirement, an earlier resumption of oral intake, and a shorter hospital stay, but a longer operative time. During the present study (range: 3.8-80 months), the cumulative rate of nonrecurrence was 67.9% at 5years after surgery, which was similar to the rate for the previous open splenectomy. Conclusions. Laparoscopic splenectomy is considered to be a suitable alternative therapeutic modality in the treatment of hematologic diseases.

Original languageEnglish
JournalSurgery
Volume131
Issue number1 SUPPL.
DOIs
Publication statusPublished - Jan 1 2002

Fingerprint

Hematologic Diseases
Splenectomy
Purpura
Idiopathic Thrombocytopenic Purpura
Hereditary Spherocytosis
Cryoglobulinemia
Autoimmune Hemolytic Anemia
Operative Time
Laparoscopy
Lymphoma
Length of Stay
Therapeutics
Pain
Control Groups

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Tanoue, K., Okita, K., Akahoshi, T., Konishi, K., Gotoh, N., Tsutsumi, N., ... Hashizume, M. (2002). Laparoscopic splenectomy for hematologic diseases. Surgery, 131(1 SUPPL.). https://doi.org/10.1067/msy.2002.120121

Laparoscopic splenectomy for hematologic diseases. / Tanoue, Kazuo; Okita, Keishi; Akahoshi, Tomohiko; Konishi, Kouzou; Gotoh, Norikazu; Tsutsumi, Norifumi; Tomikawa, Morimasa; Hashizume, Makoto.

In: Surgery, Vol. 131, No. 1 SUPPL., 01.01.2002.

Research output: Contribution to journalArticle

Tanoue, K, Okita, K, Akahoshi, T, Konishi, K, Gotoh, N, Tsutsumi, N, Tomikawa, M & Hashizume, M 2002, 'Laparoscopic splenectomy for hematologic diseases', Surgery, vol. 131, no. 1 SUPPL.. https://doi.org/10.1067/msy.2002.120121
Tanoue K, Okita K, Akahoshi T, Konishi K, Gotoh N, Tsutsumi N et al. Laparoscopic splenectomy for hematologic diseases. Surgery. 2002 Jan 1;131(1 SUPPL.). https://doi.org/10.1067/msy.2002.120121
Tanoue, Kazuo ; Okita, Keishi ; Akahoshi, Tomohiko ; Konishi, Kouzou ; Gotoh, Norikazu ; Tsutsumi, Norifumi ; Tomikawa, Morimasa ; Hashizume, Makoto. / Laparoscopic splenectomy for hematologic diseases. In: Surgery. 2002 ; Vol. 131, No. 1 SUPPL.
@article{ee298510d9464fbcaa7f654a93ac5677,
title = "Laparoscopic splenectomy for hematologic diseases",
abstract = "Background. Laparoscopic splenectomy has been demonstrated to be technically feasible and safe for the treatment of hematologic diseases. Methods. The study comprised 64 consecutive patients with chronic immune thrombocytopenia purpura (ITP) who were admitted to our hospital from 1992 to 2000 and underwent laparoscopic splenectomy. Forty-one consecutive patients with ITP who underwent open splenectomy performed at the same hospital by the same surgical team between 1986 and 2000 were selected as the control group. Results. We performed laparoscopic splenectomies for ITP, hereditary spherocytosis (HS), malignant lymphoma, autoimmune hemolytic anemia, and cryoglobulinemia. Laparoscopic surgery as compared with open surgery in ITP revealed a significantly lower pain medication requirement, an earlier resumption of oral intake, and a shorter hospital stay, but a longer operative time. During the present study (range: 3.8-80 months), the cumulative rate of nonrecurrence was 67.9{\%} at 5years after surgery, which was similar to the rate for the previous open splenectomy. Conclusions. Laparoscopic splenectomy is considered to be a suitable alternative therapeutic modality in the treatment of hematologic diseases.",
author = "Kazuo Tanoue and Keishi Okita and Tomohiko Akahoshi and Kouzou Konishi and Norikazu Gotoh and Norifumi Tsutsumi and Morimasa Tomikawa and Makoto Hashizume",
year = "2002",
month = "1",
day = "1",
doi = "10.1067/msy.2002.120121",
language = "English",
volume = "131",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Laparoscopic splenectomy for hematologic diseases

AU - Tanoue, Kazuo

AU - Okita, Keishi

AU - Akahoshi, Tomohiko

AU - Konishi, Kouzou

AU - Gotoh, Norikazu

AU - Tsutsumi, Norifumi

AU - Tomikawa, Morimasa

AU - Hashizume, Makoto

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Background. Laparoscopic splenectomy has been demonstrated to be technically feasible and safe for the treatment of hematologic diseases. Methods. The study comprised 64 consecutive patients with chronic immune thrombocytopenia purpura (ITP) who were admitted to our hospital from 1992 to 2000 and underwent laparoscopic splenectomy. Forty-one consecutive patients with ITP who underwent open splenectomy performed at the same hospital by the same surgical team between 1986 and 2000 were selected as the control group. Results. We performed laparoscopic splenectomies for ITP, hereditary spherocytosis (HS), malignant lymphoma, autoimmune hemolytic anemia, and cryoglobulinemia. Laparoscopic surgery as compared with open surgery in ITP revealed a significantly lower pain medication requirement, an earlier resumption of oral intake, and a shorter hospital stay, but a longer operative time. During the present study (range: 3.8-80 months), the cumulative rate of nonrecurrence was 67.9% at 5years after surgery, which was similar to the rate for the previous open splenectomy. Conclusions. Laparoscopic splenectomy is considered to be a suitable alternative therapeutic modality in the treatment of hematologic diseases.

AB - Background. Laparoscopic splenectomy has been demonstrated to be technically feasible and safe for the treatment of hematologic diseases. Methods. The study comprised 64 consecutive patients with chronic immune thrombocytopenia purpura (ITP) who were admitted to our hospital from 1992 to 2000 and underwent laparoscopic splenectomy. Forty-one consecutive patients with ITP who underwent open splenectomy performed at the same hospital by the same surgical team between 1986 and 2000 were selected as the control group. Results. We performed laparoscopic splenectomies for ITP, hereditary spherocytosis (HS), malignant lymphoma, autoimmune hemolytic anemia, and cryoglobulinemia. Laparoscopic surgery as compared with open surgery in ITP revealed a significantly lower pain medication requirement, an earlier resumption of oral intake, and a shorter hospital stay, but a longer operative time. During the present study (range: 3.8-80 months), the cumulative rate of nonrecurrence was 67.9% at 5years after surgery, which was similar to the rate for the previous open splenectomy. Conclusions. Laparoscopic splenectomy is considered to be a suitable alternative therapeutic modality in the treatment of hematologic diseases.

UR - http://www.scopus.com/inward/record.url?scp=0036170932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036170932&partnerID=8YFLogxK

U2 - 10.1067/msy.2002.120121

DO - 10.1067/msy.2002.120121

M3 - Article

VL - 131

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 1 SUPPL.

ER -